Is Exelon (EXC) a risky stock?
As of July 21, 2026, Clavix grades Exelon (EXC) B- for risk, a composite score of 63 out of 100 on an A+ to F scale, which puts EXC in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind EXC's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how EXC scores on each, as of July 21, 2026.
What's moving EXC's risk right now
Company-specific signals Clavix flags behind EXC's current grade, drawn from recent news and filings as of July 21, 2026.
Presented by Ernst & Young, LLP, with Illinois Governor JB Pritzker, Penny Pritzker, Microsoft's Jason Zander, Cognizant's Ravi Kumar, Exelon's Calvin Butler, Kara Swisher, WNBA H…
Earnings are roughly in line with expectations, providing little catalyst in either direction.
What a B- grade means
On the Clavix A+ to F scale, EXC's composite of 63 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell EXC or any security. Grades are risk indicators, not predictions of return. Data may be delayed.